Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neurodegeneration Markers and Neurological Course in Severe Covid-19 Infection - MARNEVO-Covid

NCT04361344 is registered in ClinicalTrials.gov with Centre Hospitalier de PAU as lead sponsor.

NCT NCT04361344
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04361344 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neurodegeneration Markers and Neurological Course in Severe Covid-19 Infection - MARNEVO-Covid
Lead sponsor
Centre Hospitalier de PAU
Phase
Not applicable
Overall status
Terminated
Start date
May 19, 2020
Completion date
October 25, 2020
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 infection, encephalitis